Recently re-established as a network member of PSI, PSI/Uganda runs health interventions in reproductive health and youth friendly services, as well as socially markets products, services and healthy behaviors that enable low-income and vulnerable communities to lead healthier lives.
Women’s Health Project
PSI is implementing the Women’s Health Project (WHP) in Uganda to increase access to and demand for affordable, high quality long-term family planning services through a network of over 175 privately owned health clinics.
The goal of the program is to reduce maternal mortality by improving the quality of reproductive health services, limiting births through increased use of long-term family planning, and providing harm reduction in the case of unsafe abortions through training health providers.
Cervical Cancer Screening and Preventive Treatment
PSI/Uganda is supporting 100 privately owned clinics within the ProFam franchise to provide cervical cancer screening using visual inspection with acetic acid (VIA) at an affordable price. Currently, 35 of these clinics have a cryotherapy machine, acting as referral sites for early treatment for cervical cancer. A pilot for HPV-DNA testing in two districts of Mbale and Soroti has also been carried out.
Youth Friendly Services (YFS) Project
PSI/Uganda is implementing a youth-friendly program using the private sector to reach girls aged 15-24 with sexual and reproductive health information and services. This project is being implemented in the districts of Wakiso, Mukono, Buikwe and Kampala in the private sector. In order to come up with a highly impactful intervention, PSI/Uganda is using the human centered design process to understand what young people want and need, and how to provide a friendly environment for them to access and use sexual and reproductive health information and services.
Maternal and Newborn Health
Clean Delivery Kits
PSI/Uganda distributes clean delivery kits for mothers, containing essential items for safe delivery. The Maama kit has been expanded to include chlorhexidine for newborn umbilical cord care following approval by the Ministry of Health. The Maama Kit is primarily purchased by relief agencies working with refugees and other priority populations, but is also sold through pharmacies.
PSI/Uganda is also socially marketing Misoprostol and Umbi-gel (chlorhexidine) to ensure that every mother has a chance to protect her life and that of her newborn baby.
Water, Sanitation and Hygiene
P&G Purifier of Water
PSI/Uganda socially markets P&G Purifier of Water, formerly, PuR; an affordable and easy-to-use water treatment product aimed at reducing sickness and death caused by diarrheal diseases. P&G Purifier of Water has also been distributed to people living with HIV/AIDS and is available in retail outlets and pharmacies across Uganda.
PSI/Uganda also socially markets WaterGuard Tab, targeted at the general population in urban and peri-urban areas. A single sodium hypochlorite tablet can treat 20 liters of water; with each dispenser of WaterGuard containing 80 tablets at a cost of 70 cents. The WaterGuard Tab serves to increase the range of point-of-use treatment options available to our target populations including people living with HIV.
Condom social marketing
PSI/Uganda socially markets TRUST condoms in a bid to increase accessibility and availability of condoms across Uganda, especially in the peri-urban and rural communities. TRUST Condoms were rebranded in 2015 to include four new variants: TRUST Classic, TRUST Scented, TRUST Studded and TRUST Ribbed.
- The Pfizer Foundation
- The Maverick Collective
- The Bill and Melinda Gates Foundation
- Ministry of Health
- Reproductive Health Uganda
- Marie Stopes Uganda
- Marie Stopes International Uganda
- Various CBOs and NGOs
- Do anti‑malarials in Africa meet quality standards? The market penetration of non quality‑assured artemisinin combination therapy in eight African countries
This paper uses national and sub-national medicine outlet surveys conducted in eight study countries (Benin, Kinshasa and Kantanga [Democratic Republic of the Congo, DRC], Kenya, Madagascar, Nigeria, Tanzania, Uganda and Zambia) between 2009 and 2015 to describe the non-QAACT market and to document trends in availability and distribution of non-QAACT in the public and private sector.
- Quality Issues with Malaria Rapid Diagnostic Test Accessories and Buffer Packaging: Findings from a 5‑Country Private Sector Project in Africa
This paper describes quality problems with buffer and accessories encountered in a project promoting private sector malaria rapid diagnostic test use in five African countries and suggests steps to avoid or more rapidly identify and resolve such problems.
- Ugandan Women’s View of the IUD: Generally Favorable but Many Have Misperceptions About Health Risks
This paper presents the results of a cross-sectional survey among 1,505 WRA exiting public and private health facilities in Uganda. We collected information on women’s attitudes, knowledge, and beliefs about the IUD, as well as their perceptions about its availability.
- Webinar: Stimulating the Market for Malaria RDTs in the Private Sector
PSI, UNITAID, Malaria Consortium, FIND, and JHSPH held a webinar to discuss leveraging the power of the private sector to transform the mRDT market in support of universal access to malaria diagnostics.
- Shaping the Family Planning Market by Strengthening the Public Sector
PSI considers total market approaches to be critical for achieving universal health coverage, especially when it comes to contraception. This program brief presents cases, supported by several different donors, which take into consideration the total family planning market.
- Transforming the Private Sector to Support Universal Malaria Diagnostic Coverage
To assure the available and use of malaria rapid diagnostic tests in the private sector, PSI and partners conducted a three-year project between 2013 and 2016 to increase the uptake of quality-assured mRDTs in private-sector markets in Kenya, Madagascar, Nigeria, Tanzania, and Uganda by taking a market development approach to identify market failures.
- Towards Subsidized Malaria Rapid Diagnostic Tests. Lessons Learned from Programmes to Subsidise Artemisinin-Based Combination Therapies in the Private Sector: a Review
Private sector subsidy programmes of ACTs have been effective in increasing availability of ACTs in the private sector and driving down average prices but struggled to crowd out antimalarial monotherapies. A subsidy of rapid diagnostic tests (RDTs) in the private sector has been recommended by governments and international donors to cope with over-treatment with ACTs and to delay the emergence of resistance to artemisinin. In order to improve the cost-effectiveness of co-paid RDTs, we should build on the lessons we learned from almost 10 years of private sector subsidy programmes of ACTs in malaria-endemic countries.
- Private Sector Readiness and Performance for Malaria Case Management in Uganda
In a nationally-representative 2015 outlet survey, 1 in 4 private sector outlets had both confirmatory testing and QA ACT treatment available. Among outlets with testing and treatment available, study results suggest positive private sector performance with respect to testing all fever patients, particularly in health facilities and drug stores, however testing was very low in pharmacies. However, not all patients seeking treatment in the private sector can or will be tested for malaria. There is need to further promote confirmatory testing and first-line ACT treatment among patients and private sector providers, as well as discourage the use of non-artemisinin therapies and inappropriate use of injectable artemisinin monotherapies for uncomplicated cases.
- Expanding Access to HIV Self-Testing: A Market Development Approach
PSI envisions a healthy market for HIVST to be one that is supported by multiple buyers and suppliers and that delivers on the 5As (Availability, Assured Quality, Appropriate Design, Awareness, and Affordability) to achieve public health goals. Realizing this vision for the HIVST market will require consideration of two key markets- public and private sectors. While HIV testing has traditionally been driven by the public sector, HIVST opens up the possibility of utilizing private sector pharmacies to expand and extend the reach of testing.
- MSI Experiences of Task Sharing Tubal Ligation by Clinical Officers in Zambia and Uganda
Task-sharing is needed in Zambia to increase access to permanent FP methods by addressing the shortage of health providers who are able to provide
tubal ligations, especially in rural areas, reducing the burden on the doctors and hospitals, and making use of existing healthcare providers through affordable, in-service training. The Zambia study aimed to show that clinical officers can feasibly provide tubal ligation in Zambia, with similar rationale for the Uganda tubal ligation task-sharing study.